🇺🇸 FDA
Pipeline program

TH1902

TH1902-CTR-0001

Phase 1 small_molecule active

Quick answer

TH1902 for Solid Tumor is a Phase 1 program (small_molecule) at WINDTREE THERAPEUTICS INC /DE/ with 1 ClinicalTrials.gov record(s).

Program details

Company
WINDTREE THERAPEUTICS INC /DE/
Indication
Solid Tumor
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials